• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

Cis-1,4-Dimethyl-cyclohexylamine Hydrochloride (CAS No. 1255098-84-0): A Comprehensive Overview

The compound Cis-1,4-Dimethyl-cyclohexylamine hydrochloride, identified by the CAS number 1255098-84-0, is a significant molecule in the field of pharmaceutical chemistry and biochemistry. This amine salt has garnered attention due to its unique structural properties and potential applications in drug development. Understanding its chemical characteristics, synthesis methods, and emerging research applications is crucial for leveraging its full potential in medicinal chemistry.

In the realm of organic chemistry, the structure of Cis-1,4-Dimethyl-cyclohexylamine hydrochloride is characterized by a cyclohexane ring substituted with two methyl groups at the 1 and 4 positions, along with an amine group that is further protonated to form the hydrochloride salt. This configuration imparts specific stereochemical and electronic properties, making it a versatile intermediate in the synthesis of more complex molecules. The cis configuration of the methyl groups contributes to its distinct spatial arrangement, which can influence its interactions with biological targets.

The synthesis of Cis-1,4-Dimethyl-cyclohexylamine hydrochloride typically involves multi-step organic reactions, starting from commercially available precursors such as cyclohexanone or cyclohexylamine derivatives. One common synthetic route includes the reduction of an N-substituted imine or oxime followed by methylation and subsequent salt formation. Advanced techniques such as catalytic hydrogenation or transition-metal-catalyzed reactions have been explored to optimize yield and purity. The choice of synthetic method often depends on the desired scale of production and the specific purity requirements for subsequent applications.

Recent advancements in pharmaceutical research have highlighted the potential of Cis-1,4-Dimethyl-cyclohexylamine hydrochloride as a building block for novel therapeutic agents. Its structural motif has been incorporated into various drug candidates targeting neurological disorders, cardiovascular diseases, and infectious diseases. For instance, studies have demonstrated its utility in developing ligands for serotonin receptors, which are implicated in mood regulation and cognitive functions. The amine moiety's ability to form hydrogen bonds and interact with aromatic rings makes it particularly suitable for designing molecules with high binding affinity.

In addition to its role in central nervous system (CNS) drug discovery, Cis-1,4-Dimethyl-cyclohexylamine hydrochloride has shown promise in the development of peripheral receptor modulators. Research has indicated that derivatives of this compound may exhibit activity at histamine H3 receptors, which are involved in various physiological processes including sleep regulation and appetite control. The hydrochloride salt form enhances solubility and bioavailability, making it an attractive candidate for further pharmacological investigation.

The stereochemistry of Cis-1,4-Dimethyl-cyclohexylamine hydrochloride plays a critical role in determining its pharmacological profile. The cis configuration ensures optimal spatial orientation for binding to biological targets, while also influencing metabolic stability and pharmacokinetic properties. Computational modeling techniques have been employed to predict how different conformations of this molecule might interact with proteins and enzymes within biological systems. These studies provide valuable insights into optimizing drug design by predicting binding affinities and potential side effects.

Emerging research also explores the use of Cis-1,4-Dimethyl-cyclohexylamine hydrochloride as a chiral auxiliary in asymmetric synthesis. Its well-defined stereochemistry allows chemists to selectively produce enantiomerically pure compounds, which are often required for pharmaceutical applications due to their distinct biological activities. By leveraging this compound as an intermediate, researchers can develop more efficient synthetic routes to complex molecules with high enantiomeric purity.

The safety profile of Cis-1,4-Dimethyl-cyclohexylamine hydrochloride is another important consideration in its application to drug development. Preclinical studies have assessed its toxicity and pharmacokinetic behavior in animal models, providing data on dosing regimens and potential side effects. These studies are essential for ensuring that any derivative compounds incorporating this structural motif are safe for human use before advancing to clinical trials.

The future prospects for Cis-1,4-Dimethyl-cyclohexylamine hydrochloride in pharmaceutical research appear promising. Ongoing studies continue to uncover new applications and refine synthetic methodologies for this versatile compound. As computational tools become more sophisticated and high-throughput screening technologies advance, researchers will be better positioned to discover novel drug candidates based on this structural scaffold.

• 665-66-7(Amantadine hydrochloride)
• 1255099-50-3(Cis-1-Butyl-4-methylcyclohexylamine HCl)
• 41100-52-1(Memantine hydrochloride)
• 26562-81-2(adamantane-1,3-diamine;dihydrochloride)
• 18392-94-4([1,1'-Bitricyclo[3.3.1.13,7]decane]-1,1'-diamine,hydrochloride (1:2))
• 13878-11-0(1-Adamantanamine,hydrochloride.(L-)- (8CI))
• 89854-70-6(1-Methylcyclohexan-1-amine Hydrochloride)
• 2277-93-2(bicyclo2.2.2octane-1,4-diamine Dihydrochloride)
• 75934-56-4(norbornan-1-amine;hydrochloride)
• 61278-98-6(N-ethylcyclohexanamine hydrochloride)